OPRM1 and Alzheimer disease: Previous research by both Weerts et al. and Heinz et al. on the MOR system demonstrated higher levels of available receptors (BPND—non-displaceable binding potential) in AD versus HC in some regions, such as the amygdala, insula, ventral striatum, putamen, and caudate [28, 29].